Return to content in this issue

 

Consensus on the definition of disease control and response assessment in chronic urticaria

Giménez-Arnau AM1, Jáuregui I2, Silvestre-Salvador JF3, Valero A4, Ferrer M5, Sastre J6, Ortiz de Frutos FJ7, Labrador-Horrillo M8, Bartra J9, Miquel Miquel J10 on behalf of Urticaria Study Group

1Dermatology Department, Hospital del Mar, Institut Mar d’investigacions Mèdiques, Universitat Pompeu Fabra, Barcelona, Spain.
2Allergology Service, Hospital Universitario Cruces, Baracaldo, Vizcaya, Spain.
3Dermatology Department, Hospital General Universitario de Alicante, Alicante, Spain.
4Allergy Department, Hospital Clínic, IDIBAPS, Barcelona, Spain.
5Department of Allergy, Clínica Universidad de Navarra, Navarra, Spain.
6Allergology Service, Hospital Universitario Fundación Jiménez Díaz and Instituto de Investigación Sanitaria (IIS), Madrid, Spain.
7Dermatology Department, Hospital Universitario 12 de Octubre, Madrid, Spain.
8Allergology Service, Hospital Universitario Vall d'Hebron, Universidad Autónoma de Barcelona, Spain.
9Allergy Department, Hospital Clínic, IDIBAPS, Barcelona, Spain.
10Dermatology Department, Hospital Arnau de Vilanova, Valencia, Spain.

J Investig Allergol Clin Immunol 2022; Vol. 32(4)
doi: 10.18176/jiaci.0820

Key words: Chronic Urticaria, Terminology as Topic, Patient Outcome Assessment, Recurrence, Consensus